Fifty 1 Labs, Inc. Announces Major
Strategic Advancements and Shareholder Updates
Significant Developments Including
Key Management Hires, Acquisitions, and New Patent
Acquisition
Melbourne, FL
-- June 13, 2024 -- InvestorsHub NewsWire -- Fifty 1
Labs, Inc. (OTCPK:
CAFI), a holding company that operates in the sports
supplement, fitness equipment, and health and wellness industries
is pleased to provide an update to its shareholders regarding
recent strategic initiatives and significant developments within
the company.
Over the past
several months, Fifty 1 Labs has been diligently working behind the
scenes to position itself for sustained long-term success and
robust growth in the sports supplement, fitness equipment, and
health and wellness industries. These efforts encompass the
following strategic actions:
Strategic
Management Appointments: Fifty 1 Labs has strategically appointed
highly experienced individuals to key management positions to
bolster its leadership team and advance its vision. These
appointments bring a wealth of industry expertise and acumen to the
company, enhancing its capabilities in navigating the competitive
landscape and seizing emerging market opportunities. The details of
these strategic management hires will be disclosed in separate
press releases, and the company will host a nationwide
teleconference to introduce the new team.
Strategic
Acquisitions: Consistent with its growth strategy, Fifty 1 Labs has
actively pursued and completed several strategic acquisitions to
expand its market presence and diversify its product offerings.
These acquisitions align with the company's commitment to
delivering high-quality products and services to its customers
while maximizing shareholder value. More comprehensive details on
these acquisitions will be shared in the coming weeks.
Revolutionary
Patent Acquisition: In addition to its recent acquisitions, Fifty 1
Labs is elated to announce the acquisition of a groundbreaking new
patent. This patent, which incorporates state-of-the-art design
within the sports equipment sector, is poised to significantly
enhance the company's product portfolio and fortify its position as
an industry leader. Detailed information regarding this innovative
patent will be unveiled shortly.
Stock Share Buyback
Initiative: Demonstrating confidence in the company's future
prospects, Fifty 1 Labs' management team has initiated a stock
share buyback program. This program underscores Fifty 1 Labs'
commitment to prudent capital allocation and its belief in the
long-term growth potential of the business. The buyback initiative
is part of the company's ongoing efforts to enhance shareholder
value.
Expansion of 51
Labs Nutrition Product Line: Fifty 1 Labs is thrilled to announce
the expansion of its acclaimed 51 Labs Nutrition product line.
Building on the success of existing offerings, the expansion
introduces new and innovative products designed to meet the
evolving needs of consumers in the sports supplement and health and
wellness markets. These new product offerings, along with scheduled
clinical trials, will be announced in the upcoming weeks. This
expansion solidifies Fifty 1 Labs' position as a premier provider
of premium nutritional supplements.
NIL Endorsement
Deals: Fifty 1 Labs has also entered into negotiations of several
Name, Image, and Likeness (NIL) endorsement deals with prominent
athletes to promote its products and enhance market visibility.
These partnerships are anticipated to elevate the market presence
of 51 products and significantly amplify marketing efforts.
Name Change
Process: The name change to Fifty 1 Labs, Inc. is currently still
in process. The company has received several rounds of questions
from FINRA and has responded to them promptly and comprehensively.
The management remains committed to ensuring that the transition is
completed smoothly and efficiently, further aligning the company's
identity with its strategic direction and vision for the
future.
"We are thrilled to
share these updates with our shareholders and the broader
investment community," said Brandon Spikes, Chairman of Consumer
Automotive Finance, Inc. "These strategic initiatives exemplify our
unwavering commitment to driving value for our shareholders,
delivering innovative products to our customers, and positioning
CAFI for sustained growth and success in the years ahead."
Fifty 1 Labs
remains steadfast in executing its strategic plan, capitalizing on
market opportunities, and delivering value to all stakeholders.
For more
information regarding 51 Supplements and Nutrition, please visit:
https://get51fit.com.
About Fifty 1 Labs,
Inc.: Fifty 1 Labs, Inc. (Ticker symbol: CAFI), a publicly traded
entity, is currently undergoing a name and symbol transition to
become Fifty 1 Labs, Inc. This transformation is accompanied by the
company's ownership of three distinct subsidiaries entrenched
within the domains of sports supplementation, fitness apparatus,
and holistic well-being. These subsidiaries include 51, LLC, a
distinguished brand specializing in sports supplementation; The
Quickness, the proud holder of a patent for pioneering athletic
training equipment meticulously crafted to enhance linebacker
development; and Astound NMN, a beacon of excellence within the
anti-aging sector, heralding the era of DNA reparation through its
premium supplements. Guided by an unwavering commitment, Fifty 1
Labs, Inc. remains at the forefront of innovation, consistently
presenting avant-garde solutions infused with state-of-the-art
technology, poised to empower individuals in their pursuit of
fitness and holistic health aspirations. Additionally, Fifty 1
Labs, Inc. remains actively engaged in pursuing strategic
acquisitions aimed at fortifying its portfolio by incorporating
profit-generating enterprises into its fold.
Safe Harbor
Statement: The information provided in this release may contain
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Identifiable by words
such as "may," "will," "should," "plans," "expects," "anticipates,"
"continue," "estimate," "project," "intend," and similar
expressions, these statements may also be made in written or oral
form in the company's filings with the U.S. Securities and Exchange
Commission, press releases, other written materials, or in oral
statements made by its officers, directors, or employees to third
parties. There can be no assurance that such statements will prove
to be accurate. The company cautions that these forward-looking
statements are further qualified by other factors including, but
not limited to, those set forth in the company's Registration
Statement on Form S-1. Forward-looking statements involve risks and
uncertainties that could cause actual results to differ materially
from those projected or anticipated. These risks and uncertainties
include, but are not limited to, general economic and business
conditions, effects of continued geopolitical unrest and regional
conflicts, competition, changes in technology and methods of
marketing, delays in completing various engineering and
manufacturing programs, changes in customer order patterns, changes
in product mix, continued success in technological advances and
delivering technological innovations, shortages in components,
production delays due to performance quality issues with outsourced
components, and various other factors beyond the company's control.
The company does not undertake any obligation to update publicly or
to revise any statements in this release, whether as a result of
new information, future events, or otherwise.
Investor Relations
Contact:
Robert Clark
844-714-2224
ir@fifty1labs.com
